Keywords: Vivus, Avanafil, Erectile dysfunction, Corcept, Corlux, Chusing's, USA, NDA filings

US NDA filings for Vivus’ ED drug avanafil and Corcept’s Corlux for Cushing’s

Article | 01 July 2011

Print This

California, USA-based Vivus (Nasdaq: VVUS) has submitted a New Drug Application has to the Food and Drug Administration seeking approval ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in